AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $291.00
- 52-wk high
- $326.63
- High
- $293.51
- 52-wk low
- $156.91
- Low
- $284.41
- Prev close
- $291.77
Smart money
Earnings
Earnings came in 65.7% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $115.5M | $59.7M | $51.7M | $63.7M |
| Cost of what it sold | $24.8M | -$26.0M | $2.1M | $3.2M |
| Gross profit | $90.6M | $85.7M | $49.6M | $60.5M |
| What it spent | ||||
| Research and development | $21.0M | $3.5M | $2.1M | $14.7M |
| Sales and admin | $28.4M | $25.0M | $20.8M | $29.1M |
| Other operating costs | -$13.8M | $37.1M | $9.3M | $8.1M |
| Total operating expenses | $35.7M | $65.6M | $32.3M | $51.9M |
| What was left | ||||
| Operating profit | $54.9M | $20.0M | $17.4M | $8.6M |
| Interest on debt | $910.0K | $1.8M | $1.7M | $1.7M |
| Profit before tax | $141.1M | $56.8M | -$24.3M | $64.3M |
| Tax | $23.9M | $12.0M | -$10.9M | $15.8M |
| Net profit | $117.3M | $44.8M | -$13.3M | $48.5M |
| EBITDA | $149.2M | $66.4M | -$14.3M | $72.4M |
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
50balanced
20D volatility
28%annualized
52-week range
$156.91$326.63
20D support
News
What the news says
2 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Invesco Ltd. (LGND holder) reports 6.1% beneficial stake in Ligand Pharmaceuticals
NeutralAug 13Ligand Pharmaceuticals Q2 Earnings Call Highlights
BullishAug 6